SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ABW'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.99A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.98A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.24A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.42A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 1a4gB-1xogA:19.6 | 1a4gB-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ARG A 157ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 (-4.9A) | 0.86A | 1a4gB-1xogA:19.6 | 1a4gB-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 372ARG A 226ALA A 248GLU A 279TYR A 406 | ABW A1000 (-2.8A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-4.9A) | 1.50A | 1a4gB-1xogA:19.6 | 1a4gB-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.21A | 1a4gB-1xogA:19.6 | 1a4gB-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 120ARG A 157ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.87A | 1a4gB-1xogA:19.6 | 1a4gB-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 152ARG A 153ILE A 224 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 ( 4.7A) | 0.23A | 1a4gB-1xogA:19.6 | 1a4gB-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 120LEU A 135ASP A 152ARG A 157TRP A 180ILE A 224ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.47A | 1l7fA-1xogA:75.0 | 1l7fA-1xogA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 119ARG A 153ARG A 372 | ABW A1000 (-3.2A)ABW A1000 (-4.1A)ABW A1000 (-2.8A) | 0.41A | 1l7fA-1xogA:75.0 | 1l7fA-1xogA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | LEU A 135ASP A 152ARG A 153ARG A 157TRP A 180ILE A 224ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294TYR A 406 | NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.47A | 1l7gA-1xogA:75.0 | 1l7gA-1xogA:99.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ASP A 152ARG A 157TRP A 180ILE A 224ARG A 226GLU A 229GLU A 278GLU A 279TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-4.9A) | 0.47A | 1l7hA-1xogA:75.0 | 1l7hA-1xogA:99.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 119ARG A 153ARG A 372 | ABW A1000 (-3.2A)ABW A1000 (-4.1A)ABW A1000 (-2.8A) | 0.38A | 1l7hA-1xogA:75.0 | 1l7hA-1xogA:99.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 119GLU A 120ARG A 153ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-4.1A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.60A | 1nncA-1xogA:73.3 | 1nncA-1xogA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_2 (NEURAMINIDASE N9) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 152ARG A 157TRP A 180ILE A 224 | ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.41A | 1nncA-1xogA:73.3 | 1nncA-1xogA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.48A | 2cmlA-1xogA:71.6 | 2cmlA-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.02A | 2cmlA-1xogA:71.6 | 2cmlA-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.71A | 2cmlA-1xogA:71.6 | 2cmlA-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 229ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.19A | 2cmlA-1xogA:71.6 | 2cmlA-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ARG A 153ARG A 157TRP A 180ILE A 224 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.44A | 2cmlA-1xogA:71.6 | 2cmlA-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 2cmlB-1xogA:71.5 | 2cmlB-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.99A | 2cmlB-1xogA:71.5 | 2cmlB-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.32A | 2cmlB-1xogA:71.5 | 2cmlB-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ARG A 153ARG A 157TRP A 180ILE A 224 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.42A | 2cmlB-1xogA:71.5 | 2cmlB-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.50A | 2cmlC-1xogA:71.7 | 2cmlC-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.00A | 2cmlC-1xogA:71.7 | 2cmlC-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.64A | 2cmlC-1xogA:71.7 | 2cmlC-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ARG A 153ARG A 157TRP A 180ILE A 224 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.47A | 2cmlC-1xogA:71.7 | 2cmlC-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.49A | 2cmlD-1xogA:71.6 | 2cmlD-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.03A | 2cmlD-1xogA:71.6 | 2cmlD-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.42A | 2cmlD-1xogA:71.6 | 2cmlD-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.65A | 2cmlD-1xogA:71.6 | 2cmlD-1xogA:69.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ARG A 153ARG A 157TRP A 180ILE A 224 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.48A | 2cmlD-1xogA:71.6 | 2cmlD-1xogA:69.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.43A | 2f0zA-1xogA:21.1 | 2f0zA-1xogA:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 157GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-4.2A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.80A | 2f0zA-1xogA:21.1 | 2f0zA-1xogA:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.53A | 2f10A-1xogA:8.0 | 2f10A-1xogA:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 157GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-4.2A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.84A | 2f10A-1xogA:8.0 | 2f10A-1xogA:21.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ARG A 153ARG A 157GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)ABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.69A | 2htqA-1xogA:62.7 | 2htqA-1xogA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 152TRP A 180ILE A 224ARG A 226 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.7A)None | 0.42A | 2htqA-1xogA:62.7 | 2htqA-1xogA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ARG A 153ARG A 157TRP A 180SER A 181ILE A 224ARG A 226GLU A 278ARG A 294TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.3A)ABW A1000 ( 4.7A)NoneABW A1000 (-4.1A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.52A | 2htuA-1xogA:63.2 | 2htuA-1xogA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 119ASP A 152GLU A 229ARG A 372 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A) | 0.40A | 2htuA-1xogA:63.2 | 2htuA-1xogA:43.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QEU_B_ACTB141_0 (PUTATIVECARBOXYMUCONOLACTONEDECARBOXYLASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | PRO A 328ASN A 348ARG A 294 | NoneNoneABW A1000 (-3.4A) | 1.06A | 2qeuB-1xogA:undetectable | 2qeuB-1xogA:14.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.47A | 3b7eA-1xogA:63.7 | 3b7eA-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.99A | 3b7eA-1xogA:63.7 | 3b7eA-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.65A | 3b7eA-1xogA:63.7 | 3b7eA-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.43A | 3b7eA-1xogA:63.7 | 3b7eA-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.45A | 3b7eB-1xogA:63.7 | 3b7eB-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.00A | 3b7eB-1xogA:63.7 | 3b7eB-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.65A | 3b7eB-1xogA:63.7 | 3b7eB-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.42A | 3b7eB-1xogA:63.7 | 3b7eB-1xogA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 119GLU A 120ARG A 153GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.41A | 3ckzA-1xogA:63.7 | 3ckzA-1xogA:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 153GLU A 229GLU A 278ARG A 294ASN A 296 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A) | 0.76A | 3ckzA-1xogA:63.7 | 3ckzA-1xogA:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 6 | ASP A 152ARG A 157TRP A 180ILE A 224ARG A 226 | ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)None | 0.64A | 3ckzA-1xogA:63.7 | 3ckzA-1xogA:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 119GLU A 120LEU A 135ARG A 157TRP A 180ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.2A)NoneNoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.67A | 3k37A-1xogA:53.4 | 3k37A-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 152ARG A 153ARG A 372 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-2.8A) | 0.42A | 3k37A-1xogA:53.4 | 3k37A-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 157TRP A 180ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneNoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A) | 0.59A | 3k37B-1xogA:53.3 | 3k37B-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153GLU A 278TYR A 406 | ABW A1000 (-4.1A)ABW A1000 (-4.1A)ABW A1000 (-4.9A) | 0.84A | 3k37B-1xogA:53.3 | 3k37B-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.69A | 3k39A-1xogA:52.7 | 3k39A-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.73A | 3k39A-1xogA:52.7 | 3k39A-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.73A | 3k39B-1xogA:52.7 | 3k39B-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.73A | 3k39C-1xogA:52.7 | 3k39C-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.77A | 3k39C-1xogA:52.7 | 3k39C-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294ARG A 372 | ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A) | 0.70A | 3k39D-1xogA:52.8 | 3k39D-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372 | ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A) | 0.74A | 3k39D-1xogA:52.8 | 3k39D-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.68A | 3k39E-1xogA:52.8 | 3k39E-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.73A | 3k39E-1xogA:52.8 | 3k39E-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.68A | 3k39F-1xogA:52.8 | 3k39F-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.72A | 3k39F-1xogA:52.8 | 3k39F-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.69A | 3k39G-1xogA:52.8 | 3k39G-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.73A | 3k39G-1xogA:52.8 | 3k39G-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.69A | 3k39H-1xogA:52.7 | 3k39H-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.73A | 3k39H-1xogA:52.7 | 3k39H-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.72A | 3k39I-1xogA:52.7 | 3k39I-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.76A | 3k39I-1xogA:52.7 | 3k39I-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.73A | 3k39J-1xogA:52.8 | 3k39J-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.77A | 3k39J-1xogA:52.8 | 3k39J-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.71A | 3k39K-1xogA:52.7 | 3k39K-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.75A | 3k39K-1xogA:52.7 | 3k39K-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.73A | 3k39L-1xogA:52.8 | 3k39L-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.77A | 3k39L-1xogA:52.8 | 3k39L-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.69A | 3k39M-1xogA:52.8 | 3k39M-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.73A | 3k39M-1xogA:52.8 | 3k39M-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.67A | 3k39N-1xogA:52.8 | 3k39N-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.71A | 3k39N-1xogA:52.8 | 3k39N-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.69A | 3k39O-1xogA:52.8 | 3k39O-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.74A | 3k39O-1xogA:52.8 | 3k39O-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.68A | 3k39P-1xogA:52.8 | 3k39P-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120LEU A 135ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.72A | 3k39P-1xogA:52.8 | 3k39P-1xogA:31.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_C_CELC682_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 7 | SER A 407LEU A 159ARG A 119ILE A 445 | NoneNoneABW A1000 (-3.2A)None | 1.06A | 3ln1C-1xogA:undetectable | 3ln1C-1xogA:20.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.49A | 3sanA-1xogA:64.1 | 3sanA-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.29A | 3sanA-1xogA:64.1 | 3sanA-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 0.68A | 3sanA-1xogA:64.1 | 3sanA-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 152ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.44A | 3sanA-1xogA:64.1 | 3sanA-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.46A | 3sanB-1xogA:64.1 | 3sanB-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.29A | 3sanB-1xogA:64.1 | 3sanB-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.63A | 3sanB-1xogA:64.1 | 3sanB-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 152ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.45A | 3sanB-1xogA:64.1 | 3sanB-1xogA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.44A | 3ti5A-1xogA:63.9 | 3ti5A-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.99A | 3ti5A-1xogA:63.9 | 3ti5A-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.62A | 3ti5A-1xogA:63.9 | 3ti5A-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.46A | 3ti5A-1xogA:63.9 | 3ti5A-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.64A | 3ti5B-1xogA:63.9 | 3ti5B-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.43A | 3ti5B-1xogA:63.9 | 3ti5B-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.00A | 3ti5B-1xogA:63.9 | 3ti5B-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.46A | 3ti5B-1xogA:63.9 | 3ti5B-1xogA:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.98A | 3ticA-1xogA:63.9 | 3ticA-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152TRP A 180GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.42A | 3ticA-1xogA:63.9 | 3ticA-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.34A | 3ticA-1xogA:63.9 | 3ticA-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120ASP A 152TRP A 180GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.60A | 3ticA-1xogA:63.9 | 3ticA-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ARG A 153ARG A 157ILE A 224ARG A 226 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)ABW A1000 ( 4.7A)None | 0.49A | 3ticA-1xogA:63.9 | 3ticA-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.42A | 3ticB-1xogA:64.0 | 3ticB-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.98A | 3ticB-1xogA:64.0 | 3ticB-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.31A | 3ticB-1xogA:64.0 | 3ticB-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 3ticB-1xogA:64.0 | 3ticB-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.42A | 3ticB-1xogA:64.0 | 3ticB-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.46A | 3ticC-1xogA:64.0 | 3ticC-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.98A | 3ticC-1xogA:64.0 | 3ticC-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.34A | 3ticC-1xogA:64.0 | 3ticC-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 0.67A | 3ticC-1xogA:64.0 | 3ticC-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.43A | 3ticC-1xogA:64.0 | 3ticC-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.44A | 3ticD-1xogA:64.0 | 3ticD-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.98A | 3ticD-1xogA:64.0 | 3ticD-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.31A | 3ticD-1xogA:64.0 | 3ticD-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 3ticD-1xogA:64.0 | 3ticD-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ARG A 153ARG A 157TRP A 180ILE A 224 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.45A | 3ticD-1xogA:64.0 | 3ticD-1xogA:41.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.62A | 4b7nA-1xogA:63.7 | 4b7nA-1xogA:40.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.04A | 4b7nA-1xogA:63.7 | 4b7nA-1xogA:40.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157TRP A 180 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.48A | 4b7nA-1xogA:63.7 | 4b7nA-1xogA:40.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.64A | 4b7qA-1xogA:63.5 | 4b7qA-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.43A | 4b7qA-1xogA:63.5 | 4b7qA-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.00A | 4b7qA-1xogA:63.5 | 4b7qA-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)ABW A1000 ( 4.7A) | 0.46A | 4b7qA-1xogA:63.5 | 4b7qA-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.70A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.52A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.03A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 135ARG A 153ARG A 157TRP A 180 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.54A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 4b7qC-1xogA:63.7 | 4b7qC-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.93A | 4b7qC-1xogA:63.7 | 4b7qC-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)ABW A1000 ( 4.7A) | 0.48A | 4b7qC-1xogA:63.7 | 4b7qC-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.66A | 4b7qD-1xogA:63.7 | 4b7qD-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.49A | 4b7qD-1xogA:63.7 | 4b7qD-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.03A | 4b7qD-1xogA:63.7 | 4b7qD-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.52A | 4b7qD-1xogA:63.7 | 4b7qD-1xogA:41.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.68A | 4cpnA-1xogA:53.5 | 4cpnA-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.95A | 4cpnA-1xogA:53.5 | 4cpnA-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 372ARG A 226ALA A 248GLU A 279TYR A 406 | ABW A1000 (-2.8A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-4.9A) | 1.50A | 4cpnA-1xogA:53.5 | 4cpnA-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 0.78A | 4cpnA-1xogA:53.5 | 4cpnA-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.44A | 4cpnA-1xogA:53.5 | 4cpnA-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.60A | 4cpnB-1xogA:53.5 | 4cpnB-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 372ARG A 226ALA A 248GLU A 279TYR A 406 | ABW A1000 (-2.8A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-4.9A) | 1.48A | 4cpnB-1xogA:53.5 | 4cpnB-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120ASP A 152ARG A 157ARG A 226GLU A 229ALA A 248GLU A 278ARG A 294TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.80A | 4cpnB-1xogA:53.5 | 4cpnB-1xogA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.62A | 4cpzA-1xogA:53.1 | 4cpzA-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 372ARG A 226ALA A 248GLU A 279TYR A 406 | ABW A1000 (-2.8A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-4.9A) | 1.45A | 4cpzA-1xogA:53.1 | 4cpzA-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.31A | 4cpzA-1xogA:53.1 | 4cpzA-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.93A | 4cpzA-1xogA:53.1 | 4cpzA-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ASP A 152ARG A 153ARG A 157TRP A 180 | NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.49A | 4cpzA-1xogA:53.1 | 4cpzA-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.59A | 4cpzB-1xogA:19.0 | 4cpzB-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.26A | 4cpzB-1xogA:19.0 | 4cpzB-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.85A | 4cpzB-1xogA:19.0 | 4cpzB-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 152ARG A 153ARG A 157TRP A 180 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.47A | 4cpzB-1xogA:19.0 | 4cpzB-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.63A | 4cpzC-1xogA:53.1 | 4cpzC-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.97A | 4cpzC-1xogA:53.1 | 4cpzC-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 372ARG A 226ALA A 248GLU A 279TYR A 406 | ABW A1000 (-2.8A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-4.9A) | 1.50A | 4cpzC-1xogA:53.1 | 4cpzC-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.19A | 4cpzC-1xogA:53.1 | 4cpzC-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.89A | 4cpzC-1xogA:53.1 | 4cpzC-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157TRP A 180 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.41A | 4cpzC-1xogA:53.1 | 4cpzC-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 4cpzD-1xogA:53.0 | 4cpzD-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.19A | 4cpzD-1xogA:53.0 | 4cpzD-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.93A | 4cpzD-1xogA:53.0 | 4cpzD-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 152ARG A 153ARG A 157TRP A 180 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.45A | 4cpzD-1xogA:53.0 | 4cpzD-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.62A | 4cpzE-1xogA:53.1 | 4cpzE-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A) | 0.93A | 4cpzE-1xogA:53.1 | 4cpzE-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157TRP A 180 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.48A | 4cpzE-1xogA:53.1 | 4cpzE-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 4cpzF-1xogA:53.0 | 4cpzF-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.94A | 4cpzF-1xogA:53.0 | 4cpzF-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.26A | 4cpzF-1xogA:53.0 | 4cpzF-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.90A | 4cpzF-1xogA:53.0 | 4cpzF-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157TRP A 180 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.43A | 4cpzF-1xogA:53.0 | 4cpzF-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.60A | 4cpzG-1xogA:52.9 | 4cpzG-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.96A | 4cpzG-1xogA:52.9 | 4cpzG-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.29A | 4cpzG-1xogA:52.9 | 4cpzG-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.92A | 4cpzG-1xogA:52.9 | 4cpzG-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157TRP A 180 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.44A | 4cpzG-1xogA:52.9 | 4cpzG-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.68A | 4cpzH-1xogA:53.0 | 4cpzH-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.98A | 4cpzH-1xogA:53.0 | 4cpzH-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.15A | 4cpzH-1xogA:53.0 | 4cpzH-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 120ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.95A | 4cpzH-1xogA:53.0 | 4cpzH-1xogA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153ARG A 157TRP A 180 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.42A | 4cpzH-1xogA:53.0 | 4cpzH-1xogA:28.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 153ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.1A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.49A | 4i00A-1xogA:62.9 | 4i00A-1xogA:47.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 153ARG A 226GLU A 229ALA A 248GLU A 278 | ABW A1000 (-4.1A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A) | 0.93A | 4i00A-1xogA:62.9 | 4i00A-1xogA:47.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ARG A 157TRP A 180ILE A 224ASN A 296 | NoneABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)ABW A1000 ( 4.0A) | 0.96A | 4i00A-1xogA:62.9 | 4i00A-1xogA:47.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.43A | 4mwrA-1xogA:74.6 | 4mwrA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ARG A 157ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 (-4.9A) | 0.99A | 4mwrA-1xogA:74.6 | 4mwrA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.26A | 4mwrA-1xogA:74.6 | 4mwrA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 120ARG A 157ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 0.66A | 4mwrA-1xogA:74.6 | 4mwrA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 135ASP A 152ARG A 153TRP A 180ILE A 224 | NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)NoneABW A1000 ( 4.7A) | 0.25A | 4mwrA-1xogA:74.6 | 4mwrA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 152ARG A 153ILE A 224ARG A 226GLU A 229 | ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 ( 4.7A)NoneABW A1000 ( 4.0A) | 1.28A | 4mwvA-1xogA:74.6 | 4mwvA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157TRP A 180ILE A 224ARG A 226GLU A 278GLU A 279ARG A 294TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-4.9A) | 0.47A | 4mwvA-1xogA:74.6 | 4mwvA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 119GLU A 229ARG A 372 | ABW A1000 (-3.2A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A) | 0.33A | 4mwvA-1xogA:74.6 | 4mwvA-1xogA:94.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.44A | 4mwxA-1xogA:74.5 | 4mwxA-1xogA:94.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 120ASP A 152ARG A 157ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.63A | 4mwxA-1xogA:74.5 | 4mwxA-1xogA:94.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 153TRP A 180ILE A 224 | ABW A1000 (-4.1A)NoneABW A1000 ( 4.7A) | 0.13A | 4mwxA-1xogA:74.5 | 4mwxA-1xogA:94.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 120LEU A 135ARG A 153ARG A 157TRP A 180SER A 181ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279TYR A 406 | ABW A1000 (-3.7A)NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.3A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-4.9A) | 0.49A | 4mx0A-1xogA:74.5 | 4mx0A-1xogA:94.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 119ASP A 152ARG A 372 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-2.8A) | 0.50A | 4mx0A-1xogA:74.5 | 4mx0A-1xogA:94.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.19A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 119GLU A 120ASP A 152GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.59A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.41A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 120GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.69A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ARG A 153ARG A 157TRP A 180ILE A 224ARG A 226 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)None | 0.64A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.42A | 5l17A-1xogA:74.8 | 5l17A-1xogA:93.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 120ARG A 157ARG A 226GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 5l17A-1xogA:74.8 | 5l17A-1xogA:93.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_2 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 135ARG A 153TRP A 180ILE A 224 | NoneABW A1000 (-4.1A)NoneABW A1000 ( 4.7A) | 0.14A | 5l17A-1xogA:74.8 | 5l17A-1xogA:93.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1481_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 4 / 6 | SER A 407ARG A 119GLU A 427TYR A 406 | NoneABW A1000 (-3.2A)NoneABW A1000 (-4.9A) | 1.10A | 5x7pA-1xogA:undetectable | 5x7pA-1xogA:15.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 119GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.50A | 6ekuA-1xogA:11.7 | 6ekuA-1xogA:17.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FHW_A_ACRA801_1 (GLUCOAMYLASE P) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ALA A 106ASP A 104GLY A 405GLU A 120TRP A 162 | NoneNoneNoneABW A1000 (-3.7A)None | 1.18A | 6fhwA-1xogA:undetectable | 6fhwA-1xogA:12.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FHW_B_ACRB801_1 (GLUCOAMYLASE P) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ALA A 106ASP A 104GLY A 405GLU A 120TRP A 162 | NoneNoneNoneABW A1000 (-3.7A)None | 1.19A | 6fhwB-1xogA:undetectable | 6fhwB-1xogA:12.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 119GLU A 120ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.47A | 6hcxA-1xogA:74.9 | 6hcxA-1xogA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 120ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 278ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.63A | 6hcxA-1xogA:74.9 | 6hcxA-1xogA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_1 (NEURAMINIDASE) |
1xog | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | TRP A 180ILE A 224GLU A 279 | NoneABW A1000 ( 4.7A)ABW A1000 (-4.5A) | 0.19A | 6hcxA-1xogA:74.9 | 6hcxA-1xogA:100.00 |